Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet

Abstract

OBJECTIVE: Apolipoprotein (apo) A-IV is an antiatherogenic apolipoprotein, which may be involved in the regulation of food intake. Plasma apoA-IV is elevated in human obesity and apoA-IV polymorphisms have been associated with the extent of obesity. Our aim was to determine the effects of weight loss on plasma apo-IV in obese adolescents and to examine the relation of apoA-IV with the degree of obesity.

DESIGN: Longitudinal intervention study of a low fat hypocaloric diet conducted in a dietary camp.

SUBJECTS: Two groups of obese adolescents (n=47 and n=29), age: 12.7±1.7 and 11.7±2.6 y, relative body mass index (RBMI): 168±24 and 175±34%, respectively.

MEASUREMENTS: Plasma total apoA-IV, apoA-I, apoB, plasma distribution of apoA-IV, leptin, lipids, and lipoproteins before and after 3 weeks of weight reduction.

RESULTS: Plasma apoA-IV decreased from 11.5±4.1 mg/dl before to 6.7±2.2 mg/dl after weight reduction in the first group (P<0.001) and to a similar extent in the second group. The relative amount of lipid-free apoA-IV and apoA-IV associated with apoA-I increased slightly, whereas apoA-IV associated with lipoproteins devoid of apoA-I decreased. ApoA-IV levels before and after weight reduction and the changes in plasma apoA-IV did not independently correlate with RBMI, weight loss, or plasma leptin.

CONCLUSION: Plasma apoA-IV decreases markedly in overweight adolescents undergoing short-term weight reduction. The decrease is not directly related to the degree of weight loss and the mechanisms underlying this reduction remain to be clarified.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Utermann G, Beisiegel U . Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur J Biochem 1979; 99: 333–343.

    Article  CAS  Google Scholar 

  2. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denefle P . Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 1996; 273: 966–968.

    Article  CAS  Google Scholar 

  3. Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K . Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 1997; 99: 1906–1916.

    Article  CAS  Google Scholar 

  4. Kronenberg F, Stuhlinger M, Trenkwalder E, Geethanjali FS, Pachinger O, von Eckardstein A, Dieplinger H . Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease. J Am Coll Cardiol 2000; 36: 751–757.

    Article  CAS  Google Scholar 

  5. Warner MM, Guo J, Zhao Y . The relationship between plasma apolipoprotein A-IV levels and coronary heart disease. Chin Med J 2001; 114: 275–279.

    CAS  Google Scholar 

  6. Kronenberg F, Kuen E, Ritz E, Junker R, König P, Kraatz G, Lhotta K, Mann JFE, Müller GA, Neyer U, Riegel W, Riegler P, Schwenger V, von Eckardstein A . Apolipoprotein A-IV serum concentrations are elevated in mild and moderate renal failure. J Am Soc Nephrol 2002; 13: 461–469.

    CAS  PubMed  Google Scholar 

  7. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC, Ailhaud G . Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem 1990; 265: 7859–7863.

    CAS  Google Scholar 

  8. Ostos MA, Conconi M, Vergnes L, Baroukh N, Ribalta J, Girona J, Caillaud JM, Ochoa A, Zakin MM . Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 1023–1028.

    Article  CAS  Google Scholar 

  9. Green PH, Glickman RM, Riley JW, Quinet E . Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J Clin Invest 1980; 65: 911–919.

    Article  CAS  Google Scholar 

  10. Lu S, Yao Y, Meng S, Cheng X, Black DD . Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J Biol Chem 2002; 277: 31929–31937.

    Article  CAS  Google Scholar 

  11. Tso P, Liu M, Kalogeris TJ, Thomson AB . The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr 2001; 21: 231–254.

    Article  CAS  Google Scholar 

  12. Lefevre M, Lovejoy JC, DeFelice SM, Keener JW, Bray GA, Ryan DH, Hwang DH, Greenway FL . Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord 2000; 24: 945–953.

    Article  CAS  Google Scholar 

  13. Heilbronn LK, Noakes M, Morris AM, Kind KL, Clifton PM . 360His polymorphism of the apolipoprotein A-IV gene and plasma lipid response to energy restricted diets in overweight subjects. Atherosclerosis 2000; 150: 187–192.

    Article  CAS  Google Scholar 

  14. Fiegenbaum M, Hutz MH . Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord 2003; 27: 484–490.

    Article  CAS  Google Scholar 

  15. Strobl W, Knerer B, Gratzl R, Arbeiter K, Lin-Lee YC, Patsch W . Altered regulation of apolipoprotein A-IV gene expression in the liver of the genetically obese Zucker rat. J Clin Invest 1993; 92: 1766–1773.

    Article  CAS  Google Scholar 

  16. Ferrante Jr AW, Thearle M, Liao T, Leibel RL . Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice. Diabetes 2001; 50: 2268–2278.

    Article  CAS  Google Scholar 

  17. Verges B, Guerci B, Durlach V, Galland-Jos C, Paul JL, Lagrost L, Gambert P . Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: a study in normoponderal and obese subjects. J Lipid Res 2001; 42: 2021–2029.

    CAS  PubMed  Google Scholar 

  18. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J . Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001; 149: 807–818.

    Article  Google Scholar 

  19. Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H . Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J Lipid Res 1994; 35: 1318–1328.

    CAS  PubMed  Google Scholar 

  20. Ezeh B, Haiman M, Alber HF, Kunz B, Paulweber B, Lingenhel A, Kraft HG, Weidinger F, Pachinger O, Dieplinger H, Kronenberg F . Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls. J Lipid Res 2003; 44: 1523–1529.

    Article  CAS  Google Scholar 

  21. Sherman JR, Weinberg RB . Serum apolipoprotein A-IV and lipoprotein cholesterol in patients undergoing total parenteral nutrition. Gastroenterology 1988; 95: 394–401.

    Article  CAS  Google Scholar 

  22. Zimmerman J, Kaufmann NA, Fainaru M, Eisenberg S, Oschry Y, Friedlander Y, Stein Y . Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis 1984; 4: 115–123.

    Article  CAS  Google Scholar 

  23. Sun Z, Larson IA, Ordovas JM, Barnard JR, Schaefer EJ . Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations. Atherosclerosis 2000; 151: 381–388.

    Article  CAS  Google Scholar 

  24. Sun Z, Welty FK, Dolnikowski GG, Lichtenstein AH, Schaefer EJ . Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma. Am J Clin Nutr 2001; 74: 308–314.

    Article  CAS  Google Scholar 

  25. Weinberg RB, Dantzker C, Patton CS . Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 1990; 98: 17–24.

    Article  CAS  Google Scholar 

  26. Koenig J, Elmadfa I . Food-based dietary guidelines—the Austrian perspective. Br J Nutr Suppl 1999; 81: S31–S35.

    Article  Google Scholar 

  27. Ehnholm C, Tenkanen H, Deknijff P, Havekes L, Rosseneu M, Menzel HJ, Tiret L . Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: The EARS study. Atherosclerosis 1994; 107: 229–238.

    Article  CAS  Google Scholar 

  28. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF . Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295.

    Article  CAS  Google Scholar 

  29. Rosenbaum M, Nicolson M, Hirsch J, Murphy E, Chu F, Leibel RL . Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 1997; 82: 3647–3654.

    CAS  Google Scholar 

  30. Dubuc GR, Phinney SD, Stern JS, Havel PJ . Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 1998; 47: 429–434.

    Article  CAS  Google Scholar 

  31. Morton NM, Emilsson V, Liu YL, Cawthorne MA . Leptin action in intestinal cells. J Biol Chem 1998; 273: 26194–26201.

    Article  CAS  Google Scholar 

  32. Hassink SG, Sheslow DV, de Lancey E, Opentanova I, Considine RV, Caro JF . Serum leptin in children with obesity: relationship to gender and development. Pediatrics 1996; 98: 201–213.

    CAS  Google Scholar 

  33. Lagrost L, Gambert P, Meunier S, Morgado P, Desgres J, d'Athis P, Lallemant C . Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J Lipid Res 1989; 30: 701–710.

    CAS  PubMed  Google Scholar 

  34. Schwarz S, Haas B, Luley C, Schafer JR, Steinmetz A . Quantification of apolipoprotein A-IV in human plasma by immunonephelometry. Clin Chem 1994; 40: 1717–1721.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by the Jubliäumsfonds der Österreichischen Nationalbank (Project #8830 to W Strobl and Project #9331 to F Kronenberg) and in part by the Austrian Science Fund (Project #13649 BIO to W Strobl).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Strobl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lingenhel, A., Eder, C., Zwiauer, K. et al. Decrease of plasma apolipoprotein A-IV during weight reduction in obese adolescents on a low fat diet. Int J Obes 28, 1509–1513 (2004). https://doi.org/10.1038/sj.ijo.0802789

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802789

Keywords

This article is cited by

Search

Quick links